The etiologies, pathophysiology, and alternative/complementary treatment of asthma

Alternative Medicine Review

Volumn 6, Issue 1, 2001, Pages 20-47

  Miller, A L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CYANOCOBALAMIN; CYTOKINE; FLAVONOID; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; LIPID; NATURAL PRODUCT; OMEGA 3 FATTY ACID; PYRIDOXINE; QUERCETIN; SELENIUM; STEROL DERIVATIVE; STEROLIN DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN; ZINC;

ALTERNATIVE MEDICINE; ASTHMA; CYTOKINE PRODUCTION; FEEDBACK SYSTEM; HUMAN; MANIPULATIVE MEDICINE; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOTHERAPY; REVIEW; SYMPTOMATOLOGY;

AIR POLLUTION; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMPLEMENTARY THERAPIES; DEHYDRATION; DIETARY SUPPLEMENTS; GASTROESOPHAGEAL REFLUX; HUMANS; INTERLEUKINS; METALS, HEAVY; MIND-BODY RELATIONS (METAPHYSICS); MYCOSES; PLANT EXTRACTS; PSYCHOPHYSIOLOGY; RESPIRATORY MUCOSA; RISK FACTORS; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0035129682     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (204)

1. Sleep and psychological disturbance in nocturnal asthma
2. Air pollution in allergic asthma
3. In vivo and in vitro proinflammatory effects of particulate air pollution (PM10)
4. Epidemiology of pollution-induced airway disease in Scandinavia and Eastern Europe
5. Genetic and environmental factors contributing to the onset of allergic disorders
6. Is infant immunization a risk factor for childhood asthma or allergy?
7. Pertussis vaccination and asthma: Is there a link?
8. Lack of association between pertussis vaccination and symptoms of asthma and allergy
9. The role of Th2 type CD4+ T cells and Th2 type CD8+ T cells in asthma
10. T cells and chronic asthma
11. Modulation of T-helper cell populations: Potential mechanisms of respiratory hypersensitivity and immune suppression
12. T-lymphocyte dysregulation in asthma
13. Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases
14. Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation
15. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge
16. Immunoregulatory networks in asthma
17. A role for Th2 T-memory cells in early airway obstruction
18. IL-4 differentiates naive CD8+ T cells to a "Th2-like" phenotype: A link between viral infections bronchial asthma
19. Treating asthma and rhinitis as one disease
20. Nasal symptoms in bronchial asthma
21. House-dust mite allergens: A major risk factor for childhood asthma in Australia
22. Exposure to house-dust mite allergen (Der p 1) and the development of asthma in childhood. A prospective study
23. The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma
24. Dust mite allergens and asthma: Report of a second international workshop
25. Asthmatic symptoms and indoor levels of micro-organisms and house dust mites
26. Risk factors for asthma in inner city children
27. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions
28. The effect of high-efficiency and standard vacuum-cleaners on mite, cat and dog allergen levels and clinical progress
29. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma
30. Adult asthmatics sensitized to cats and dogs: Symptoms, severity, and bronchial hyperresponsiveness in patients with furred animals at home and patients without these animals
31. Asthma and the home environment
32. Life-style and behavioral risk factors associated with asthma morbidity in adults
33. Sensitization to individual allergens as risk factors for lower FEV1 in young adults
34. Role of current and childhood exposure to cat and atopic sensitization
35. High prevalence of sensitization to cat allergen among Japanese children with asthma, living without cats
36. Dog and cat allergens and asthma among school children in Los Alamos, New Mexico, USA: Altitude 7,200 feet
37. Markers of inflammation and bronchial reactivity in children with asthma, exposed to animal dander in school dust
38. Relevance of allergens from cats and dogs to asthma in the northernmost province of Sweden: Schools as a major site of exposure
39. Domestic allergens in public places III: House dust mite, cat, dog and cockroach allergens in British hospitals
40. Washing the dog reduces dog allergen levels, but the dog needs to be washed twice a week
41. The effect of air filtration on airborne dog allergen
42. Placebo controlled double-blind food challenge in asthma
43. Egg and milk allergy in asthmatic children: Assessment by immulite allergy food panel, skin prick tests and double-blind placebo-controlled food challenges
44. Nutritional triggers in asthma
45. Patients' perceptions of food-induced asthma
46. Development of a standardized methodology for double-blind, placebo-controlled food challenge in patients with brittle asthma and perceived food intolerance
47. Gastrointestinal symptoms in patients with asthma
48. Clinical aspects of allergic disease. Increased intestinal permeability in bronchial asthma
49. Chronic asthma and rhinitis due to Candida albicans, epidermophyton, and trichophyton
50. Mycoflora in bronchial asthma
51. (1†3) beta-D-glucan and endotoxin in house dust and peak flow variability in children
52. Sensitivity to fungal allergens is a risk factor for life-threatening asthma
53. Yeast fungi in patients with allergic diseases: Species variety and sensitivity to antifungal drugs
54. The role of fungal allergy in bronchial asthma
55. IgE-, IgA-, and IgG-antibody responses to carbohydrate and protein antigens of Candida albicans in asthmatic children
56. Dendritic cells discriminate between yeasts and hyphae pf the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo
57. Immunity to Candida albicans: Th1, Th2 cells and beyond
58. A TH1-TH2-like switch in candidiasis: New perspectives for therapy
59. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis
60. Interleuin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans
61. Studies on INF-gamma production by peripheral blood mononuclear cells cultured with Candida antigen in asthmatics
62. Humoral and cellular immunity to Candida albicans in patients with bronchial asthma
63. Persistence of viruses in upper respiratory tract of children with asthma
64. Chlamydia pneumoniae, asthma, and COPD: What is the evidence?
65. Chlamydia pneumoniae serological status is not associated with asthma in children or young adults
66. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma
67. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: A quantitative review
68. Respiratory, syncytial virus in early life and risk of wheeze and allergy by age 13 years
69. Immune-mediated disease pathogenesis in respiratory syncytial virus infection
70. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry
71. Second-hand smoke is an adjuvant for T helper-2 responses in a murine model of allergy
72. Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the rat
73. The effects of acid perfusion of the esophagus on ventilation and respiratory sensation
74. Why do the published data fail to clarify the relationship between gastroesophageal reflux and asthma?
75. Airway response to acid instillation in esophagus in bronchial asthma
76. Gastroesophageal reflux and asthma: A possible reflex mechanism
77. Gastroesophageal reflux-induced bronchoconstriction. An intraesophageal acid infusion study using state-of-the-art technology
78. Respiratory response to intraesophageal acid infusion in asthmatic children during sleep
79. Gastroesophageal reflux disease and asthma: The two are directly related
80. Airway response to acid instillation in esophagus in bronchial asthma
81. Gastroesophageal reflux induced bronchoconstriction: Vagolytic doses of atropine diminish airway responses to esophageal acid infusion
82. Autonomic regulation in asthmatics with gastroesophageal reflux
83. Comparison of airway responses following tracheal or esophageal acidification in the cat
84. Scintigraphic detection of gastro-pulmonary aspiration in patients with respiratory disorders
85. Pulmonary aspiration as a consequence of gastroesophageal reflux: A diagnostic approach
86. Asthma as a cause for, rather than a result of, gastroesophageal reflux
87. Treatment of childhood asthma with parenteral vitamin B12, gastric reacidification, and attention to food allergy, magnesium, and pyridoxine. Three case reports with background and an integrated hypothesis
88. Hydrochloric acid: Physiological functions and clinical implications
89. Exercise-induced asthma: Is it the right diagnosis in elite athletes?
90. Models and mechanisms of exercise-induced asthma
91. Allergy and sports: Exercise-induced asthma
92. Hydration in severe acute asthma
93. Is there a unifying hypothesis for exercise-induced asthma?
94. Alcoholic drinks: Important triggers for asthma
95. Psychological issues in the treatment of asthmatic patients
96. Effects of depressive symptoms on health-related quality of life in asthma patients
97. Emotions and stress increase respiratory resistance in asthma
98. Daily psychosocial factors predict levels and diurnal cycles of asthma symptomatology and peak flow
99. Psychophysiologic reactivity in asthmatic children: A cholinergically mediated confluence of pathways
100. Oxygen radicals in lung pathology
101. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma
102. Increased superoxide release from alveolar macrophages in symptomatic asthma
103. Altered lung antioxidant status in patients with mild asthma
104. Serum levels of antioxidant vitamins (alpha tocopherol, beta carotene, and ascorbic acid) in children with bronchial asthma
105. Relationship between dietary vitamin C intake and pulmonary function in the first national health and nutrition examination survey (NHANES 1)
106. Dietary antioxidants and lung function in the general population
107. Does dietary intake of vitamins C and E influence lung function in older people?
108. Vitamin C status and respiratory function
109. Effect of ascorbic acid on response to methacholine challenge in asthmatic subjects
110. Lack of acute effects of ascorbic acid on spirometry and airway responsiveness to histamine in subjects with asthma
111. The attenuation of exercise-induced bronchospasm by ascorbic acid
112. Nutrition and asthma
113. Asthma and vitamin C
114. Depressed plasma pyridoxal phosphate concentrations in adult asthmatics
115. Pyridoxine treatment of childhood bronchial asthma
116. Double-blind trial of pyridoxine (vitamin B6) in the treatment of steroid-dependent asthma
117. Theophylline attenuates circulating vitamin B6 levels in children with asthma
118. Relation between theophylline and circulating vitamin levels in children with asthma
119. Hypomagnesemia in chronic, stable asthmatics: Prevalence, correlation with severity and hospitalization
120. Assessment of magnesium status in patients with bronchial asthma
121. Bronchial reactivity and intracellular magnesium: A possible mechanism for the bronchodilating effect of magnesium in asthma
122. Role of magnesium in regulation of lung function
123. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample
124. Investigation of the effect of short-term change in dietary magnesium intake in asthma
125. Magnesium in the management of asthma: Critical review of acute and chronic treatments, and Deutsches Medizinisches Zentrum's (DMZ's) clinical experience at the dead sea
126. Rapid infusion of magnesium sulfate obviates need for intubation in status asthmaticus
127. Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma
128. Intravenous magnesium sulphate in the management of moderate to severe acute asthmatic children nonresponding to conventional therapy
129. Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy
130. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma
131. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma
132. Effect of parenteral magnesium sulfate on pulmonary function in bronchial asthma
133. Effect of intravenous magnesium infusion on salbutamol-induced bronchodilatation in patients with asthma
134. Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations
135. Intravenous magnesium sulfate in acute severe asthma
136. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: A systematic review of the literature
137. Efficacy of magnesium sulfate in acute adult asthma: A meta-analysis of randomized trials
138. Plasma zinc, copper and copper/zinc ratio in intrinsic asthma
139. Zinc and copper status in children with bronchial asthma and atopic dermatitis
140. Zinc and copper status of allergic children
141. Modern diets and diseases: NO-zinc balance
142. Zinc-controlled Th1/Th2 switch significantly determines development of diseases
143. Zinc and immunity
144. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans
145. Zinc deficiency: Changes in cytokine production and T-cell subpopulations in patients with head and neck cancer and in noncancer subjects
146. Selenium status is decreased in patients with intrinsic asthma
147. Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients
148. Reduced selenium in asthmatic subjects in New Zealand
149. Antioxidant status in asthma
150. Selenium supplementation in intrinsic asthma
151. Leukotriene antagonism in asthma and rhinitis
152. Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease
153. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma
154. Leukotrienes, fish-oil, and asthma
155. Fish oil in asthma
156. The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Survey (NHANES 1)
157. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children
158. Effect of dietary supplementation with polyunsaturated fatty acids on bronchial hyperreactivity in subjects with seasonal asthma
159. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production
160. Effect of dietary supplementation with fish oil lipids on mild asthma
161. Effect of tylophorine, a major alkaloid of Tylophora indica, on immunopathological and inflammatory reactions
162. The possible site of anti-asthmatic action of Tylophora asthmatica on pituitary-adrenal axis in albino rats
163. Tylophora indica in bronchial asthma. A controlled comparison with a standard anti-asthmatic drug
164. A crossover double-blind study on Tylophora indica in the treatment of asthma and allergic rhinitis
165. Mechanism of anti-inflammatory actions of curcumine and boswellic acids
166. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata
167. Effect of salia guggal ex-Boswellia serrata on cellular and humoral immune responses and leucocyte migration
168. Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study
169. Flavonoids, leucocyte migration, and eicosanoids
170. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells
171. Flavonoid inhibition of human basophil histamine release stimulated by various agents
172. Quercetin; monograph
173. Beta-sitosterol and beta-sitosterol glycoside stimulate human peripheral blood lymphocyte proliferation: Implications for their use as an immunomodulatory vitamin combination
174. Flow cytometric analysis of the TH1-TH2 shift in allergic individuals using Moducare‰ (sterols/sterolins)
175. Immunomodulation in HIV/AIDS: The Tygerberg/Stellenbosch University experience
176. Plant sterols and sterolins: A review of their immune-modulating properties
177. An extract of Petasites hybridus is effective in the prophylaxis of migraine
178. Identification and characterization of inhibitors of peptido-leukotriene synthesis from Petasites hybridus
179. Gastroprotective effects by extracts of Petasites hybridus: The role of inhibition of peptido-leukotriene synthesis
180. Relaxant effects of petasins in isolated guinea pig trachea and their structure-activity relationships
181. Study on clinical properties and mechanisms of action of Petasites in bronchial asthma and chronic obstructive bronchitis
182. Effect of acupuncture on bronchial asthma
183. Clinical observation on 25 cases of hormone dependent bronchial asthma treated by acupuncture
184. Combined use of acupuncture and blood injection at the back-shu points for treatment of allergic asthma - A report of 80 cases
185. Immediate antiasthmatic effect of acupuncture in 192 cases of bronchial asthma
186. Effects of acupuncture on immunoglobins in patients with asthma and rheumatoid arthritis
187. Acupuncture in asthma and pulmonary disease: An analysis of efficacy and safety
188. Asthma: Palpation and injections
189. Asthma, rheumatoid arthritis and the autoimmune system
190. Treating pain by specific injection therapy. The infraspinatus reflex
191. Asthma severity, psychophysiological indicators of arousal, and immune function in asthma patients undergoing biofeedback-assisted relaxation
192. Fifteen-month follow-up with asthmatics utilizing EMG/incentive inspirometer feedback
193. Transcendental meditation and asthma
194. Evaluation of yoga therapy programme for patients of bronchial asthma
195. Effect of yoga training on exercise tolerance in adolescents with childhood asthma
196. An integrated approach of yoga therapy for bronchial asthma: A 3-54-month prospective study
197. Yoga for bronchial asthma: A controlled study
198. Children with asthma have improved pulmonary functions after massage therapy
199. Osteopathic manipulative treatment applications for the emergency department patient
200. Manual therapy for asthma
201. A comparison of active and simulated chiropractic manipulation as adjunctive treatment for childhood asthma
202. Chronic asthma and chiropractic spinal manipulation: A randomized clinical trial